{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:29:29Z","timestamp":1747178969950,"version":"3.40.5"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2021,1,2]]},"DOI":"10.1080\/14737167.2021.1851600","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T20:05:09Z","timestamp":1605297909000},"page":"159-168","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19."],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-0773","authenticated-orcid":false,"given":"Vakaramoko","family":"Diaby","sequence":"first","affiliation":[{"name":"College of Pharmacy, HPNP 3317, University of Florida, Gainesville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4391-5345","authenticated-orcid":false,"given":"Reem D.","family":"Almutairi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Business and Administration Sciences, MCPHS University, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Pharmacy, HPNP 3317, University of Florida, Gainesville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-1053","authenticated-orcid":false,"given":"Richard K.","family":"Moussa","sequence":"additional","affiliation":[{"name":"Th\u00e9orie \u00c9conomique, Mod\u00e9lisation et Applications (ThEMA), Universit\u00e9 de Cergy-Pontoise, France and Ecole Nationale Sup\u00e9rieure de Statistiques et d\u2019Economie Appliqu\u00e9e (ENSEA)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdrahmane","family":"Berthe","sequence":"additional","affiliation":[{"name":"Northwest Territories Government, Yellowknife, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"#cr-split#-cit0002.1","unstructured":"World Health Organization. Europe, WHO announces COVID-19 outbreak a pandemic. [updated 2020 Mar 12"},{"key":"#cr-split#-cit0002.2","unstructured":"cited 2020 Mar 17]. Available from: http:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covid-19-outbreak-a-pandemic"},{"key":"#cr-split#-cit0003.1","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19), Situation Report. [Updated 2020 Oct 2"},{"key":"#cr-split#-cit0003.2","unstructured":"cited 2020 Oct 6]. Available from: https:\/\/www.who.int\/publications\/m\/item\/weekly-update-on-covid-19-2-october-2020"},{"key":"#cr-split#-cit0004.1","unstructured":"Center for Disease Control and Prevention (CDC). [Updated 2020 Oct 6"},{"key":"#cr-split#-cit0004.2","unstructured":"cited 2020 Oct 6]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/cases-updates\/cases-in-us.html"},{"key":"#cr-split#-cit0005.1","unstructured":"Center for Disease Control and Prevention (CDC). Coronavirus disease 2019 (COVID-19), prevent getting sick. [Updated 2020 Apr 11"},{"key":"#cr-split#-cit0005.2","unstructured":"cited 2020 Apr 11]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/social-distancing.html"},{"key":"#cr-split#-cit0006.1","unstructured":"USFDA, Coronavirus Disease 2019 (COVID-19). [Updated 2020 Apr 4"},{"key":"#cr-split#-cit0006.2","unstructured":"cited 2020 Apr 11]. Available from: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/counterterrorism-and-emerging-threats\/coronavirus-disease-2019-covid-19"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4608"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15094"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101658"},{"key":"#cr-split#-cit0010.1","unstructured":"USFDA. Drugs@FDA: FDA-approved drugs. [Updated 2020 Mar 19"},{"key":"#cr-split#-cit0010.2","unstructured":"cited 2020 Apr 11]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=009768"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"#cr-split#-cit0012.1","unstructured":"USFDA. Coronavirus (COVID-19) update: FDA continues to facilitate development of treatments. [Updated 2020 Mar 19"},{"key":"#cr-split#-cit0012.2","unstructured":"cited 2020 Apr 11]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-continues-facilitate-development-treatments"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0689-4"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.04.003"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00927-1"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2020.0071"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101873"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2020.04.016"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061867"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.7.682"},{"key":"#cr-split#-cit0021.1","unstructured":"USFDA. Questions, and answers on FDA's adverse event reporting system (FAERS). [Updated 2020 Apr 4"},{"key":"#cr-split#-cit0021.2","unstructured":"cited 2020 Apr 17]. Available from: https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers"},{"key":"#cr-split#-cit0022.1","unstructured":"USFDA. FDA adverse event reporting system (FAERS) electronic submissions. [Updated 2020 Mar 3"},{"key":"#cr-split#-cit0022.2","unstructured":"cited 2020 Apr 17]. Available from: https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-electronic-submission"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157753"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1159\/000319590"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8630"},{"key":"cit0026","first-page":"e201834","author":"Mercuro N","year":"2020","journal-title":"JAMA Cardiol"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.05.014"},{"key":"cit0028","first-page":"S66","volume":"4","author":"Palleria C","year":"2013","journal-title":"JPP"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04037.x"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.1531"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2021.1851600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T12:49:59Z","timestamp":1620478199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2021.1851600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,2]]}},"alternative-id":["10.1080\/14737167.2021.1851600"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2021.1851600","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"type":"print","value":"1473-7167"},{"type":"electronic","value":"1744-8379"}],"subject":[],"published":{"date-parts":[[2020,12,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}